A Mixed Methods Feasibility Trial of PKCι Inhibition with Auranofin in Asymptomatic Patients with Ovarian Cancer

PURPOSE: This trial was undertaken to 1) determine the feasibility of enrolling asymptomatic ovarian cancer patients with Ca-125 elevation to a trial with the PKCι inhibitor, auranofin, and 2) understand patients’ perceptions of Ca-125 monitoring. METHODS: Asymptomatic ovarian cancer patients with C...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncology
Autori principali: Jatoi, Aminah, Breitkopf, Carmen Radecki, Foster, Nathan R., Block, Matthew S., Grudem, Megan, Hendrickson, Andrea Wahner, Carlson, Rachel E., Barrette, Brigitte, Karlin, Nina, Fields, Alan P.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2014
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4536897/
https://ncbi.nlm.nih.gov/pubmed/25502607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000369257
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi